Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
Clinical trial NCT06169410 · UNKNOWN
Trial details
- NCT number
- NCT06169410
- Sponsor
- Yang Jianjun, PhD
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-30
- Primary completion
- 2025-12-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.